The integrated workflows provide a complete pipeline for drug discovery, from lead identification to lead optimization.

Various in silico  Computational Methodologies are employed to predict how molecules interact with biological targets and their potential therapeutic properties

To decrease the regulatory risk from the molecular design stage. The platform also covered the early prediction of toxicity

Compound screening

·lIntegrated screening models of      herbicide/fungicide/insecticide.
·Support large scale screening of new compounds via in-house and filed trials.

Technical support

·Quick response to end user demands
·Product Repositioning
·Dig market potential of new compounds

Open source to partners

Promote in-depth cooperation with key partners across R&D, production and commercialization.

Strong synthesis and scale-up capability

·+100ChemistsR&Dteam for synthetic process,fermentationprocess and fluorine chemistry
·+10engineersforindustrialization

Analysis & QC

·1OECDGLPLab&2CNASLabs ·QA&QCTeam(30+Analysts)

Manufacturing Platform

5 manufacturing sites across China

Involvement of toxicity and regulatory assessment

in  early discovery stage

Project based registration process

leverage both Limin and Sufarm functions

Resource to support registration

OECD/GLP lab, Regulatory Affair,Registration advisors

Building the tailored digital system to manage big data and project process management

Data-Driven: utilizing large datasets of chemical compounds, protein structures, and biological information to build Structure Property Relation (SAR) and refine the design process.

Japan innovation center opened in 2025.02, locatedin Yokohama. It is supporting China innovation team and exploring global frontier technologies

A strong global consultant team is deeply engaged for the discovery process, methodology, structure design, regulatory and marketing. They come from US, EU, Japan and China, and all have rich experience in former MNC leading agriculture companies.